drugset / Trial / NCT00299013
Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to investigate whether a novel dosage form of a prednisolone ester, called COLAL-PRED®, is useful in the treatment of ulcerative colitis.
Timeline
- Start
- 2006-03
- Primary completion
- 2008-04
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Prednisolone | Other / unclassified | 40 mg | Oral |
| Subject | Prednisolone sodium metasulfobenzoate | Unknown | 40 mg | Oral |
| Subject | Prednisolone sodium metasulfobenzoate | Unknown | 60 mg | Oral |
| Subject | Prednisolone sodium metasulfobenzoate | Unknown | 80 mg | Oral |